Correction: Price trends of reimbursed oncological drugs in Switzerland in 2005-2019: A descriptive analysis.

Correction: Price trends of reimbursed oncological drugs in Switzerland in 2005-2019: A descriptive analysis.

[This corrects the article DOI: 10.1371/journal.pone.0259936.].

Bibliographic Details
Main Author:	PLOS ONE Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0264610

Similar Items

Price trends of reimbursed oncological drugs in Switzerland in 2005–2019: A descriptive analysis
by: Yael Rachamin, et al.
Published: (2021-01-01)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023-12-01)

Pricing and reimbursement challenges for fixed dose combination cardiovascular drugs and intravenous oncologies
by: Cronin-Fine, Drew
Published: (2012)

Correction: Prevalence and trend of major transfusion-transmissible infections among blood donors in Western China, 2005 through 2010.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: First description of a herpesvirus infection in genus Lepus.
by: PLOS ONE Staff
Published: (2020-01-01)

Correction: Are network growth and the contributions to congresses associated with publication success? A pediatric oncology model.
by: PLOS ONE Staff
Published: (2019-01-01)

Drug pricing and reimbursement decision making systems in Mongolia
by: Gereltuya Dorj, et al.
Published: (2017-12-01)

Pricing and reimbursement of orphan drugs: the need for more transparency
by: Simoens Steven
Published: (2011-06-01)

Correction: spatially explicit trends in the global conservation status of vertebrates.
by: PLOS ONE Staff
Published: (2015-01-01)

Price-Cutting Trends in New Drugs after Listing in South Korea: The Effect of the Reimbursement Review Pathway on Price Reduction
by: Sungju Kim, et al.
Published: (2020-07-01)

Correction: Clinical, virological and immunological features of HIV-positive children internationally adopted in France from 2005-2015.
by: PLOS ONE Staff
Published: (2019-01-01)

Timeline of Authorization and Reimbursement for Oncology Drugs in Italy in the Last 3 Years
by: Mariangela Prada, et al.
Published: (2017-01-01)

Oncology monoclonal antibodies expenditure trends and reimbursement projections in the emerging Balkan market
by: Mihajlo B Jakovljevic
Published: (2014-03-01)

Correction: Cancer-related mortality in Peru: Trends from 2003 to 2016.
by: PLOS ONE Staff
Published: (2020-01-01)

Medicines pricing and reimbursement in Canada
by: Chris BONNETT, et al.
Published: (2022-06-01)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
by: David Elvira, et al.
Published: (2023-10-01)

Correction: Century-Long Warming Trends in the Upper Water Column of Lake Tanganyika.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: trends of tuberculosis case notification and treatment outcomes in the Sidama zone, Southern Ethiopia: ten-year retrospective trend analysis in urban-rural settings.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Descriptive anatomy and three-dimensional reconstruction of the skull of the early tetrapod Acanthostega gunnari Jarvik, 1952.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: correction: paraphyly of the subgenus Sintonius (Diptera, Psychodidae, Sergentomyia): status of the malagasy species. Creation of a new subgenus and description of a new species.
by: PLOS ONE Staff
Published: (2015-01-01)

The reimbursement decision speed for oncology new drugs in China and its determinant factors
by: Xingyue Zhu, et al.
Published: (2023-10-01)

Correction: The Maya Preclassic to Classic transition observed through faunal trends from Ceibal, Guatemala.
by: PLOS ONE Staff
Published: (2020-01-01)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
by: Elizabeth Docteur, et al.
Published: (2015-12-01)

Drugs price and reimbursement regulation: comparators, endpoints and role of the cost-effectiveness
by: Claudio Jommi, et al.
Published: (2022-09-01)

Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
by: Di Wu, et al.
Published: (2022-04-01)

Correction: Identifying and quantifying heterogeneity in high content analysis: application of heterogeneity indices to drug discovery.
by: PLOS ONE Staff
Published: (2015-01-01)

Medicines regulation, pricing and reimbursement in Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022-03-01)

Trends in individual reimbursement of orphan drugs in Latvia in 2008–2011
by: Logviss K., et al.
Published: (2014-01-01)

Correction: A Systematic Review of Tobacco Smoking Prevalence and Description of Tobacco Control Strategies in Sub-Saharan African Countries; 2007 to 2014.
by: PLOS ONE Staff
Published: (2016-01-01)

Correction: Donor Financing of Global Mental Health, 1995-2015: An Assessment of Trends, Channels, and Alignment with the Disease Burden.
by: PLOS ONE Staff
Published: (2017-01-01)

Correction: Climatic stability drives latitudinal trends in range size and richness of woody plants in the Western Ghats, India.
by: PLOS ONE Staff
Published: (2020-01-01)

Correction: Higher plasma drug levels in elderly people living with HIV treated with darunavir.
by: PLOS ONE Staff
Published: (2021-01-01)

Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe
by: Krzysztof Piotr Malinowski, et al.
Published: (2020-10-01)

Personalized Reimbursement Model (PRM) program: A real-world data platform of cancer drugs use to improve and personalize drug pricing and reimbursement in France.
by: Pierre-Alexandre Squara, et al.
Published: (2022-01-01)

Correction: Global adoption of 6-month drug-resistant TB regimens: Projected uptake by 2026.
by: PLOS ONE Staff
Published: (2024-01-01)

Correction: The impact of textual elements on the comprehensibility of drug label instructions (DLIs): A systematic review.
by: PLOS ONE Staff
Published: (2021-01-01)

Correction: Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
by: PLOS ONE Staff
Published: (2015-01-01)

Correction: Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
by: PLOS ONE Staff
Published: (2021-01-01)

Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021
by: Catherine Lau, et al.
Published: (2022-10-01)

Drug pricing and reimbursement information management: processes and decision making in the global economy
by: Dimitrios Tsourougiannis
Published: (2017-01-01)